pcos

  1. madman

    Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome

  2. madman

    Integrating Endocrine Insight Into Adolescent Acne Care

    * Kristina Derrick, MD, ScM—named Rookie of the Year at the 2026 Masters of Pediatric Dermatology (MOPD) meeting—brings a dual-disciplinary perspective that reframes acne not simply as a cutaneous disorder, but as a reflection of pubertal physiology, metabolic health, and androgen signaling...
  3. madman

    Heart Disease Risks in Women with PCOS: New Insights, Therapies, and Gaps in Research

    In this webinar, Dr. Licy Yanes Cardozo presents the heightened cardiovascular risks in women with PCOS, the mechanisms underlying these risks, current treatments available, potential new therapies, and the existing knowledge gaps in women's health research. Summary Complications of...
  4. madman

    Groundbreaking Study Links DNA Variants to Testosterone Overproduction in PCOS

    Dr. Dunaif * For the first time, we have shown how specific inherited DNA variants in PCOS change gene activity and increase testosterone production. That moves us from statistical association to biological mechanism. Research could pave way for new therapies to treat polycystic ovary...
  5. madman

    Initiative Calls for Updated Standards in Testing for Suspected Low Testosterone

    * Dr. Dunaif was a featured speaker at this CDC meeting. “We hope that the CDC initiative will finally lead to accurate testosterone measurements by clinical laboratories almost 20 years after the Endocrine Society position statement. It is exceptionally disappointing that major clinical...
  6. madman

    Genomic Insights into PCOS: Causal Mechanisms & Classifications

    Keynote lecture on: Deconstructing a Syndrome – Genomic Insights into PCOS Causal Mechanisms and Classification Speaker: Andrea Dunaif, Icahn School of Medicine at Mount Sinai, USA
  7. madman

    Serum Free Testosterone: Precision LC-MS/MS for PCOS Diagnosis

    * A standardized ED method is recommended to effectively separate FT from the serum matrix. * With the rapid development of liquid chromatography-tandem mass spectrometry (LC-MS/MS), the ED separation combined with LC-MS/MS has become the “gold standard” for quantifying FT [4]. * Serum FT...
  8. madman

    Controversy and Lack of Consensus: Hormone Therapy for Primary Prevention

    Dr. Roger Lobo true vet here! In this episode of the You Are Not Broken podcast, Dr. Kelly Casperson and Dr. Roger Lobo discuss the use of hormone therapy for primary prevention in women. They address the controversy surrounding hormone therapy and the lack of consensus among healthcare...
  9. madman

    Advancing PCOS Care: PCOS Challenge and CDC Host Key Meeting to Set Hormone Testing Standards

    ATLANTA, July 25, 2024 /PRNewswire/ -- In a pivotal moment for improving the diagnosis and treatment of polycystic ovary syndrome (PCOS), an important PCOS Stakeholder Meeting is being held to address the urgent need for better diagnostic accuracy and health outcomes. This meeting, organized by...
  10. madman

    PCOS: A challenging condition with both reproductive and metabolic components

    Dr. Kathleen Hoeger discusses PCOS, a challenging condition with both reproductive and metabolic components. Diagnosis involves evaluating menstrual cycling, androgenic symptoms, and the appearance of the ovaries on ultrasound. Treatment varies depending on the individual’s needs and may include...
  11. madman

    Androgen excess and metabolic and cardiovascular disorders

    Dr. John C Stevenson
  12. madman

    Recent advances in emerging PCOS therapies

    Recent advances in emerging PCOS therapies (2023) Kelly A. Glendining and Rebecca E. Campbell Abstract Polycystic ovary syndrome is a prevalent endocrinopathy involving androgen excess and anovulatory infertility. The disorder is also associated with many comorbidities such as obesity and...
  13. madman

    Androgens & Cardiovascular Diseases in Women

    Join Dr. Licy Yanes-Cardozo as she expands on her research exploring the role of androgens on cardiovascular physiology in cis and transgender patients.
  14. madman

    Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman

    Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman (2022) Angelica Lindén Hirschberg Abstract Postmenopausal hyperandrogenism is a condition caused by relative or absolute androgen excess originating from the ovaries and/or the adrenal glands. Hirsutism, i.e., increased...
  15. madman

    Practical Approach to Hyperandrogenism in Women

    INTRODUCTION The word androgen is derived from the Greek words andros and genao, which translate to “a man” and “produce or create,” respectively. Hyperandrogenism is therefore any state with excess production of “male” hormones, although these hormones are normally found in women at lower...
  16. madman

    The Role of Genetics, Epigenetics and Lifestyle in PCOS Development

    Abstract Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disease affecting about 20–25% of women of reproductive age. Different mechanisms could contribute to the development of its typical clinical features (i.e. hirsutism, acne, oligo-amenorrhea, alopecia). Some genetic and...
  17. Nelson Vergel

    NAC Improved Response to Clomid in Women with PCOS

    Send to Fertil Steril. 2005 Feb;83(2):367-70. N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome. Rizk AY1, Bedaiwy MA, Al-Inany HG. Abstract OBJECTIVE: To evaluate the effect of N-acetyl-cysteine (NAC), a...
Back
Top